Bergenia ciliata
Bergenia ciliata · Accepted scientific name
Scientific literature: Very Sparse (14 studies) · ★☆☆☆☆
Bergenia ciliata is a medicinal plant known for its significant therapeutic potential, particularly through the use of its rhizome, root, and leaf components. Various preparations, including aqueous, ethanolic, and methanolic extracts, have been studied to harness its diverse biological activities. These extracts demonstrate potent antibacterial, antioxidant, anticancer, antifungal, and antiviral properties against pathogens such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The plant's medicinal efficacy is largely attributed to key chemical constituents like bergenin, gallic acid, 3-O-galloylepicatechin, and epicatechin. Consequently, Bergenia ciliata serves as a rich source of bioactive compounds for pharmacological development.
- Synonyms
- Megasea Ciliata · Saxifraga Thysanodes · 3 more
- Common names
- Not available
- Family
- Saxifragaceae
- Distribution
- Not available
- Plant Parts
- Rhizome · Root
Classification
Common Names
Bergenia ciliata is a versatile plant recognized by a diverse array of common names across different regions. It is frequently referred to as Fringed Bergenia, Hairy Bergenia, or Hairy Leaf Bergenia due to its distinct physical characteristics. In certain local contexts, the species is known by the name Natsei-gamon. Additionally, it holds the traditional name Paakhanbhed in various herbal communities. These various designations highlight the plant's wide recognition and cultural significance.
Sources: Catalogue of Life (COL)
Synonyms
Bergenia ciliata is a botanical subject that has been classified under several different scientific names throughout history. Taxonomists have frequently utilized synonyms such as Bergenia ligulata var. ciliata and Bergenia thysanodes to describe this specific plant. Its historical nomenclature also includes transitions into the genera Megasea and Saxifraga. Specifically, the plant has been identified as both Saxifraga ciliata and Saxifraga ligulata var. ciliata in various studies. Understanding these overlapping relationships is essential for anyone studying the complex evolutionary lineage of this species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bergenia ciliata belongs to the diverse kingdom Plantae, showcasing the vast complexity of the natural world. Within this kingdom, the species is classified under the class Equisetopsida. It further resides in the order Saxifragales, which helps scientists understand its evolutionary lineage. As a member of the family Saxifragaceae, it shares specific morphological traits with its botanical relatives. Ultimately, this resilient plant is defined by its placement within the genus Bergenia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Saxifragales |
| Family | Saxifragaceae |
| Genus | Bergenia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bergenia ciliata is a resilient plant found throughout various regions of the Asian-Tropical landscape. Its natural range extends across the Indian Subcontinent, where it thrives in diverse ecological niches. Specifically, the species is well-documented within the mountainous terrains of Nepal. It also maintains a significant presence throughout the West Himalaya, adapting to the unique conditions of those high-altitude environments. These overlapping distributions highlight the plant's importance to the regional flora of South Asia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Bergenia ciliata is characterized by its distinct herb growth form. This plant remains entirely self-supporting as it develops within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Bergenia ciliata is a highly regarded medicinal plant recognized for its diverse and potent biological activities. Extensive research has confirmed its significant antibacterial properties, demonstrating effectiveness against various human bacterial pathogens. Furthermore, the plant serves as a rich source of bioactive compounds that provide strong antioxidant and anticancer effects. Its therapeutic profile is further enhanced by notable antifungal and antimalarial activities, supporting its traditional use in treating various ailments. These multifaceted pharmacological relationships highlight the immense potential of the species for modern drug development and biomedical applications.
Compounds
Bergenia ciliata is a highly valued medicinal plant recognized for its diverse array of bioactive secondary metabolites. Extensive phytochemical analyses have confirmed that the plant contains essential compounds such as phenols and alcohols. Specifically, research highlights that Bergenia ciliata contains bergenin, which serves as a major component in various therapeutic extracts. Furthermore, the plant is a known source of gallic acid and the specific flavonoid 3-O-galloylepicatechin. These diverse chemical constituents underpin the plant's significant pharmacological potential in treating various ailments.
Conditions
Bergenia ciliata possesses significant antibacterial properties that allow it to effectively treat various human pathogens. Research indicates that this medicinal plant can treat the bacteria Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Its diverse pharmacological profile further demonstrates that Bergenia ciliata treats anti-inflammatory conditions within the body. By leveraging these bioactive compounds, the plant serves as a potent antibacterial agent against a range of harmful microbes.
Preparations
Bergenia ciliata is prepared as various extracts to investigate its diverse medicinal properties. Specifically, the plant is prepared as aqueous and ethanolic extracts to test for promising antimicrobial activity against microorganisms. Research also shows that Bergenia ciliata is prepared as methanolic extracts, which have demonstrated potent anti-herpes viral and anti-influenza viral activities. Additionally, the plant is prepared as an aqueous extract through methods like maceration to facilitate the green synthesis of biogenic silver nanoparticles. These different forms of Bergenia ciliata extracts serve as the foundation for evaluating hypoglycemic, antibacterial, and neuroprotective potential.
Parts used
Bergenia ciliata is a medicinal herb characterized by several distinct anatomical parts, including the rhizome, root, and leaf. Research into the plant's rhizome has revealed significant antibacterial properties and a wide spectrum of antioxidant potential. Furthermore, the root extracts have been utilized in the green synthesis of silver nanoparticles to enhance antimicrobial effectiveness against various pathogens. Studies on the leaves and roots also indicate that most extracts possess hypoglycemic activity, which is valuable for treating diabetes mellitus. Together, these different components of the plant demonstrate a diverse range of bioactive properties that could support future pharmaceutical developments.